Position in AIM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,880
-$4,770 QoQ
Shares Held
46,003
+53.8% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 16 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AIM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. AIM ranks #513 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in AIM
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,880 | 46,003 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $17,650 | 29,918 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,633 | 17,376 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $44,349 | 16,186 | Shares | Defined | 2025-11-12 | |
| 2025-03-31 | $63,759 | 531,334 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $92,802 | 464,016 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $125,284 | 464,016 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $148,379 | 401,027 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $165,278 | 351,657 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $154,729 | 351,657 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $161,762 | 351,657 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $255,206 | 380,905 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $163,789 | 380,905 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $118,080 | 380,905 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $221,568 | 382,014 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $297,970 | 382,014 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $395,330 | 372,953 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $343,116 | 372,953 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $753,365 | 372,953 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $756,262 | 351,750 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $798,472 | 351,750 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $420,633 | 234,991 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $476,201 | 221,489 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $383,859 | 154,782 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||